Form 8-K - Current report
September 13 2023 - 1:44PM
Edgar (US Regulatory)
0001419051
false
0001419051
2023-09-12
2023-09-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): September 12, 2023
THERAPEUTIC
SOLUTIONS INTERNATIONAL, INC. |
(Exact
Name of Registrant as Specified in its Charter) |
Nevada |
|
000-54554 |
|
45-1226465 |
(State
or other jurisdiction of
incorporation or organization) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification Number) |
701
Wild Rose Lane |
Elk
City, Idaho 83525 |
(Address
of Principal Executive Offices and Zip Code) |
|
(760)
295-7208 |
(Issuer’s
telephone number) |
|
|
(Former
Name or Former Address, if Changed Since Last Report) |
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title of
each class |
|
Trading Symbol(s) |
|
Name of each exchange on which
registered |
Common Stock |
|
TSOI |
|
OTC Markets |
Item
8.01 Other Events – Letter to Shareholders and Interested Parties.
To
All Shareholders and Interested Parties:
In
order to correct the record regarding Therapeutic Solutions International, Inc. (“TSOI” and/or the “Company”)
and Campbell Neurosciences, Inc. (“CNSI”) relevant to their interests regarding the corporate action filed with FINRA to
verify documentation and information and its associated 8-K filed 3/24/2023, the following resolutions based on shareholder consents
and approvals of the boards of both TSOI and CSNI were adopted:
RESOLVED,
that the Board of TSOI, with the approval and agreement of the Board of CNSI, believes that the dividend to TSOI shareholders of CNSI
stock is in the best interest of the Company and relevant shareholders, the Board, therefore, pursuant to Nevada Revised Statutes Section
NRS 78.215, and unanimously approved by TSOI Series A Preferred Stock holders representing at least 51% of the voting stock of TSOI,
copies of which are appended hereto, authorizes and approves TSOI, who currently owns 15,660,000 (52%) of the shares of Campbell Neurosciences,
Inc. (“CNSI”) common stock, pursuant to a called special meeting, discussed and unanimously approved the filing of the 8-K
to address and correct any confusion that appears to have been created by prior PR, 8-Ks, and public information regarding Sandbox Dental
Labs, Inc., (“Sandbox DL”), a Delaware corporation, namely the changing of its name to Campbell Neurosciences, Inc., which
was not completed and public notice should likely have been done at that time, and the licensing of certain patents and related transactions
in order to begin the process of spinning off the subsidiary from TSOI, the dividend distribution being part of said process, which have
been rescinded in order to capitalize CNSI, as filed and certified in Delaware on 2/1/2021;
RESOLVED
FURTHER, it is advisable to correct the record regarding CNSI the board of directors of the Company, with approval and consent of the
board of CNSI, has determined that the 8-K, in correcting the above-described misapprehension and publicly state the intent to dissolve
Sandbox DL and have authorized and begun steps to be taken in that regard, including filing of final tax returns with Delaware and the
authority to file the Certification of Dissolution once proof of final tax returns are acquired;
RESOLVED
FURTHER, relevant to the same validation process and FINRA responses re the dividend distribution corporate action, the 8-K shall also
disclose a change in the ratio resulting from a disclosed issuance that was eligible to be included in the Dividend Offer on the deadline,
to affirm the desired issuance of a dividend consisting of 10,000,000 shares of TSOI holdings in CNSI to TSOI shareholders ratio is
now 1 to 0.00358 of TSOI common to CNSI common, respectively, the dividend distribution is conditional based upon an election to
accept by the TSOI shareholder owning stock as of 4/7/2023, beneficial ownership of stock date of April 7, 2023 (“Dividend Offer”)
remains the same, as well as Dividend Offer Date of April 8, 2023 and a closing date of July 10, 2023 (“The Dividend Offer will
remain open for Ninety (90) days from the Dividend Offer Date”).
In
addition, a correction of the percentage of shares that TSOI currently owns of CNSI, which has been stated with different results, including
the 8-K of 3/24/2023, to clear up any shareholder, public or regulator confusion, that the actual percentage of ownership being 52%
(15,660,000/30,045,000 shares issued = .5212), as stated above.
RESOLVED
FURTHER, that an amended 8-K shall be filed once FINRA is satisfied all documents and information are verified regarding the public disclosure
of the dividend distribution to be posted on OTC Markets;
RESOLVED
FURTHER, that the officers of the Company are hereby authorized to do and perform any and all such acts, including execution and issuance
of any and all documents, as said officers shall deem necessary or advisable, to carry out the purposes of the foregoing resolution.
A facsimile copy of this resolution shall have the same legal effect as an original of the same.
Item
9.01 Financial Statements and Exhibits.
Exhibit
Index
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
September 13, 2023
THERAPEUTIC
SOLUTIONS INTERNATIONAL, INC.
By: |
/s/
Timothy Dixon |
|
By: |
/s/
Thomas Ichim |
|
Timothy
Dixon |
|
|
Thomas
Ichim |
|
Chief
Executive Officer, Director |
|
|
Director |
Exhibit 99.1
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-1_003.jpg)
Exhibit 99.2
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-2_006.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-2_007.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-2_008.jpg)
Exhibit 99.3
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-3_009.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-3_010.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-3_011.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-3_012.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-3_013.jpg)
Exhibit 99.4
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_014.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_015.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_016.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_017.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_018.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_019.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_020.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_021.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_022.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_023.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_024.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-4_025.jpg)
Exhibit 99.5
Exhibit 99.6
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-6_001.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-6_002.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-6_003.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-6_004.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-6_006.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-6_007.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-6_008.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-6_009.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-6_010.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-6_011.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-6_012.jpg)
Exhibit 99.7
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_001.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_002.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_003.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_004.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_005.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_006.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_007.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_008.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_009.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_010.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_011.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-7_012.jpg)
Exhibit 99.8
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_001.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_002.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_003.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_004.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_005.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_006.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_007.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_008.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_009.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_010.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_011.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-8_012.jpg)
Exhibit 99.9
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-9_001.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-9_002.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-9_003.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-9_004.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-9_005.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-9_006.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-9_007.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-9_008.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-9_009.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-9_010.jpg)
![](https://www.sec.gov/Archives/edgar/data/1419051/000149315223032442/ex99-9_011.jpg)
Exhibit 99.10
Exhibit 99.11
Exhibit 99.12
Exhibit 99.13
Exhibit 99.14
v3.23.2
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Jul 2024 to Aug 2024
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Aug 2023 to Aug 2024